Insider Trading April 13, 2026 04:49 PM

Exzeo CEO Paresh Patel Buys $30,760 of Company Stock

Purchase follows quarterly results that matched analyst expectations and drew positive aftermarket response

By Priya Menon XZO
Exzeo CEO Paresh Patel Buys $30,760 of Company Stock
XZO

Exzeo Group Chief Executive Officer Paresh Patel acquired 2,000 shares of the company's common stock on April 10, 2026, paying $15.38 per share for a total of $30,760. After the trade Patel directly owns 1,608,013 shares and retains options to buy 5,000,000 additional shares under an October 1, 2021 grant. The transaction comes as Exzeo reported fourth-quarter and full-year 2025 results consistent with analyst forecasts, including diluted EPS of $0.25 and quarterly revenue of $53.32 million.

Key Points

  • CEO Paresh Patel purchased 2,000 shares on April 10, 2026, at $15.38 per share, totaling $30,760.
  • After the purchase, Patel directly owns 1,608,013 shares and holds options to buy 5,000,000 shares granted October 1, 2021, with a $23 exercise price that began vesting October 1, 2022 and continues vesting quarterly.
  • Exzeo's fourth-quarter and full-year 2025 results matched analysts' forecasts - diluted EPS of $0.25 and quarterly revenue of $53.32 million - and the announcement was followed by positive aftermarket trading and analyst attention.

Exzeo Group, Inc. (NASDAQ: XZO) reported an insider purchase by its chief executive officer, Paresh Patel. On April 10, 2026, Patel bought 2,000 shares of Exzeo common stock at a price of $15.38 per share, for a total outlay of $30,760.

Following the acquisition, Patel's direct holdings in the company stand at 1,608,013 shares. In addition to his current share ownership, Patel holds option rights to acquire 5,000,000 shares of Exzeo common stock under an option grant dated October 1, 2021. Those options carry an exercise price of $23 per share. The option award began vesting in installments starting October 1, 2022, and continues to vest on a quarterly schedule.

Separately, Exzeo disclosed its financial performance for the fourth quarter and the full fiscal year 2025. The reported results were in line with analysts' earnings estimates, with diluted earnings per share of $0.25 and quarterly revenue of $53.32 million. The company described the results as indicative of robust growth. The earnings release prompted a positive reaction in aftermarket trading and attracted the attention of various analyst firms, though no specific upgrades or downgrades were disclosed in connection with the announcement.

For investors seeking additional resources on the company, InvestingPro subscribers are noted to have access to eight additional exclusive tips about XZO, along with comprehensive Pro Research Reports that cover more than 1,400 U.S. equities.

These corporate disclosures - the insider purchase, the status of outstanding incentive options, and the quarterly financial metrics that matched consensus estimates - offer a snapshot of Exzeo's current position as viewed through insider activity and recent market reception. The combination of an insider buy and a post-earnings aftermarket uptick underscores the immediate market response to the company's reported fourth-quarter and full-year 2025 performance.

Risks

  • Insider ownership and option positions can change over time - the future vesting schedule and potential option exercises may alter share supply and insider incentives, affecting equity dynamics.
  • While earnings and revenue matched consensus, the report did not include detailed analyst upgrades or downgrades; the lack of specific follow-up from analysts introduces uncertainty about longer-term analyst sentiment.
  • Aftermarket reactions can be short lived - initial positive trading following the earnings release may not reflect sustained market performance or longer-term operational outcomes.

More from Insider Trading

NeonC Technologies C.A.O. David Suh Jr. Buys $1,000 of Stock as Company Advances Financing and Clinical Program Apr 13, 2026 Carlson Capital Reduces RWAY Stake With $3.69M Sale as Runway Reports Weaker Quarter Apr 13, 2026 BridgeBio CEO Kumar Disposes Nearly $6M in Stock via Trusts Under 10b5-1 Plan Apr 13, 2026 Hippo CEO Disposes of $130,250 in Stock; Company Signals Ongoing Operational Momentum Apr 13, 2026 Liquidia CEO Executes $1.00M Share Sale as Company Advances Yutrepia Launch Apr 13, 2026